PetVivo Holdings, Inc. announced that Health Canada has formally acknowledged Spryng® with OsteoCushion® Technology as a veterinary medical device for use in Canada. Spryng is a veterinarian-administered, intra-articular injection designed for the management of lameness and other joint-related afflictions, including osteoarthritis, in cats, dogs, and horses. The product is already commercially available in the United States and through select international distribution partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PetVivo Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9629448-en) on January 21, 2026, and is solely responsible for the information contained therein.